China Health Group
Advancing Health, Shaping the Future
China Health Group Ltd. is a leading China-based provider of new-drug technology and market services, focused on global API & formulation development, clinical studies, and regulatory registration. Since 1998, we have developed 7 VSmart® drug-delivery systems, completed 300+ national new-drug preclinical studies, and filed 100+ patents worldwide. With clients across North America, Europe, Africa, and Asia, we deliver end-to-end solutions.
Who We Are
We serve life-science and healthcare organizations across the drug value chain—API & formulation R&D, clinical research, and regulatory submissions. With 8 global R&D centers, we support China’s top-50 pharma companies and expand our international network.
Mission & Vision
Mission: Combine advanced healthcare management and connected technologies to expand access to quality care.
Vision: Build a research-driven care system that creates lasting value for patients, providers, and industry partners.
Focus Areas
Clinical & Real-World Studies (RWS)
Regulatory Registration & Compliance Filing
API & Formulation Technology Development
Hospital Management & Internet-Hospital Operations
Specialty Care & Telemedicine
Rehab Care & Medical Tourism Programs
Service Process
Needs Assessment
Align goals, scope, and compliance boundaries
Solution Definition
Solution Definition
Study Design
Define protocol, data plan, and QC system
Execution
Deploy resources and manage delivery
Compliant Delivery
Submit deliverables; support review and communication
Ongoing Support
Review, optimize, and scale a repeatable partnership model
Strengths
Why Choose Us?
Built on 7 VSmart® drug-delivery platforms and deep R&D, enabling innovation from lab to application.
Integrate RWS/RWD with clinical systems to produce verifiable evidence and actionable paths.
8 global R&D centers across North America, Europe, Africa, and Asia—delivering one-stop support.
VP-Tech Transfer, VP-PDS, VP-CRO, VP-API, and VP-Mart cover the full value chain, improving speed and cost efficiency.
Long-term build-up of clinical site resources and expert panels to accelerate delivery.
Strict quality management and compliance—sustainable, audit-ready support for partners.
Key Metrics
7
VSmart® Drug-Delivery Platforms
300+
National New-Drug Preclinical Studies
8
Global R&D Centers
400+
Clinical Sites & Field Network
Partnership Inquiry
Contact China Health Group to explore partnership. We’ll propose an initial approach and alignment path based on your needs.